Chemotherapy for Epithelial Ovarian Cancer
By Maurie Markman, MD
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
MODERATOR: Brian A. Meltzer, MD, MBA
DISCUSSANTS: Leo R. Zacharski, MS, MD, and Steven R. Deitcher, MD
Letter From the Editors
A Standing Ovation for a Change in How We Treat Patients With Cancer —Forever
By Daniel D. Von Hoff, MD, FACP, and J. Lyle Bootman PhD
The Case for Geriatric Oncology
By Lodovico Balducci, MD
Pharmacology of Antineoplastic Agents in Older Cancer Patients
By J. Andrew Skirvin, PharmD, Sunitha Vemulapalli, MD, and Stuart M. Lichtman, MD
Pharmacy Practice
The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer:
What Should Patients Be Told?
By Judith A. Smith, PharmD, BCOP
Assessing the Older Cancer Patient
By Martine Extermann, MD, PhD
Metastasis of an Esophageal Carcinoma to the Soft Tissue in the Elbow
By Arun Kumar, MD, Rajeev Kulkarni, MD, Emmanuel C. Besa, MD, and Carolyn E. Grotkowski, MD
Cancer Mortality in the Elderly, 1960–1998: A Worldwide Approach
By Carlo La Vecchia, MD, Franca Lucchini, BSc, Eva Negri,ScD, and Fabio Levi, MD
Use of Colony-Stimulating Factors in the Elderly Cancer Patient
By Gary H. Lyman, MD, MPH, FRCP (Edin), Lodovico Balducci, MD, and Yemi Agboola, MS
Right Tool, Right Time, Right Reason
By J. Lyle Bootman, PhD, and Daniel D. Von Hoff, MD, FACP
Palliative Care Options for Advanced Prostate Cancer
By Amir V. Kaisary, MA, ChM, FRCS, and Ross Knight, MRCS
Treatment and Management of Cancer in the Frail Elderly
By Zeba S. Geloo, MD, and William B. Ershler, MD
Surgical Staging for Endometrial Cancer
By James W. Orr, Jr, MD, Phillip Y. Roland, MD, Pamela J. Orr, RN, OCN, and Dara D. Leichter, RN, OCN
The Metabolism of Prostate Malignancy:
Insight Into the Pathogenesis of Prostate Cancer and New Approaches for Its Diagnosis and Treatment
By Leslie C. Costello, PhD, and Renty B. Franklin, PhD
The Contemporary Management of Colorectal Cancer
By David L. Grinblatt, MD, and Richard L. Schilsky, MD
Prostate Cancer Immunotherapy: Choices for Patients and Clinicians
By Michael L. Salgaller, PhD
Are You Ready For Some Ethics, Some Success, Some Cytoprotectants, and Some New Board Members?
By Daniel D. Von Hoff, MD, FACP, and J. Lyle Bootman, PhD
Oncology Ethics Forum
Ethical Perspectives on Oncology Care
By Terri Maxwell, RN, MSN, AOCN
Economics of Cancer Drug Development
By Michael Dickson, PhD, and Gene Reeder, PhD